TheWell Bioscience Launches RocketCell™ AOF B27-Like, N2-Like, and N2B27-Like Supplements, Advancing NAMs and Future GMP Development
SOUTH BRUNSWICK TOWNSHIP, N.J., Nov. 12, 2026 /PRNewswire/ -- TheWell Bioscience, a developer of an integrated animal origin-free 3D cell culture platform, announced the launch of RocketCell™ S1, S2, and S3 Supplements, AOF, a new portfolio of animal origin-free supplements designed to...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.